Sandra Sedo Net Worth

The estimated Net Worth of Sandra Sedo is at least $2.39 Milhão dollars as of 24 August 2020. Ms. Sedo owns over 2,914 units of Cardiovascular Systems stock worth over $1,349,340 and over the last 7 years she sold CSII stock worth over $195,797. In addition, she makes $840,723 as Chief Compliance Officer at Cardiovascular Systems.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Ms. Sedo CSII stock SEC Form 4 insiders trading

Sandra has made over 5 trades of the Cardiovascular Systems stock since 2017, according to the Form 4 filled with the SEC. Most recently she sold 2,914 units of CSII stock worth $93,073 on 24 August 2020.

The largest trade she's ever made was selling 2,914 units of Cardiovascular Systems stock on 24 August 2020 worth over $93,073. On average, Sandra trades about 206 units every 41 days since 2017. As of 24 August 2020 she still owns at least 67,467 units of Cardiovascular Systems stock.

You can see the complete history of Ms. Sedo stock trades at the bottom of the page.

Sandra Sedo biography

Sandra Marie Sedo serves as Chief Compliance Officer of the Company. Ms. Sedo joined us in June 2016 as Corporate Compliance Officer and was promoted to Chief Compliance Officer in July 2017. Prior to joining us, Ms. Sedo consulted for medical device companies in the legal and compliance areas. From 2005 to 2015, Ms. Sedo was employed by Medtronic, Inc. in various legal and compliance roles, and prior to that was a partner at Dorsey & Whitney LLP, which provides legal services to us from time to time.

What is the salary of Sandra Sedo?

As the Chief Compliance Officer of Cardiovascular Systems, the total compensation of Sandra Sedo at Cardiovascular Systems is $840,723. There are 8 executives at Cardiovascular Systems getting paid more, with Scott Ward having the highest compensation of $4,718,960.

How old is Sandra Sedo?

Sandra Sedo is 56, she's been the Chief Compliance Officer of Cardiovascular Systems since 2016. There are 11 older and 14 younger executives at Cardiovascular Systems. The oldest executive at Cardiovascular Systems Inc. is Augustine Lawlor, 64, who is the Independent Director.

What's Sandra Sedo's mailing address?

Sandra's mailing address filed with the SEC is 1225 OLD HIGHWAY 8 NW, , ST. PAUL, MN, 55112.

Insiders trading at Cardiovascular Systems

Over the last 16 years, insiders at Cardiovascular Systems have traded over $72,999,461 worth of Cardiovascular Systems stock and bought 949,532 units worth $8,687,068 . The most active insiders traders include Capital Management Lp Camber, Augustine Lawlor, eCapital Ltdmaverick Capital.... On average, Cardiovascular Systems executives and independent directors trade stock every 14 days with the average trade being worth of $338,920. The most recent stock trade was executed by Martha Goldberg Aronson on 15 August 2022, trading 2,411 units of CSII stock currently worth $48,220.

What does Cardiovascular Systems do?

Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company's orbital atherectomy system treats calcified and fibrotic plaque in arterial vessels throughout the leg and heart and addresses many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives.

Complete history of Ms. Sedo stock trades at Cardiovascular Systems

Cardiovascular Systems executives and stock owners

Cardiovascular Systems executives and other stock owners filed with the SEC include:

• Scott Ward,
  Chairman of the Board, President, Chief Executive Officer
• Rhonda Robb,
  Chief Operating Officer
• Scott Raymond Ward B.Sc., M.S., MS,
  Chairman, Pres & CEO
• Scott Raymond Ward M.S., MS, B.Sc.,
  Chairman, Pres & CEO
• Jeffrey Points,
  Chief Financial Officer
• Alexander Rosenstein,
  General Counsel and Corporate Secretary
• Ryan Egeland,
  Chief Medical Officer
• Rhonda J. Robb,
  Chief Operating Officer
• Sandra Sedo,
  Chief Compliance Officer
• Jeffrey S. Points,
  Chief Financial Officer
• Alexander Rosenstein,
  Gen. Counsel & Corp. Sec.
• Dr. Ryan D. Egeland M.D., Ph.D.,
  Chief Medical Officer
• Edward Brown,
  Independent Director
• Augustine Lawlor,
  Independent Director
• Martha Aronson,
  Independent Director
• Erik Paulsen,
  Independent Director
• William Cohn,
  Independent Director
• Stephen Stenbeck,
  Independent Director
• Stephen Rempe,
  Chief Human Resource Officer
• Kelvin Womack,
  Independent Director
• David Whitescarver,
  Vice President - Corporate Development and Intellectual Property
• John Hastings,
  Vice President - Manufacturing and Operations
• Stephen J. Rempe,
  Chief HR Officer
• David S. Whitescarver,
  VP of Corp. Devel. & Intellectual Property
• Sandra M. Sedo,
  Chief Compliance Officer
• John M. Hastings,
  Exec. VP of Operations & Technology
• John E. Nielsen,
  VP of Investor Relations & Corp. Communications
• Brent G Blackey,
  Director
• Leslie Trigg,
  Director
• Capital Management Lp Camber,
  10% owner
• Scott A Bartos,
  Director
• Laurence L Betterley,
  Chief Financial Officer
• Kevin J. Kenny,
  Chief Operating Officer
• Laura Gillund,
  Chief Talent Officer
• Sachin H. Jain,
  Director
• Capital Ltdmaverick Capital...,
  
• Gary M Petrucci,
  Director
• Paul A. Koehn,
  SVP Quality & Operations
• James E Flaherty,
  Chief Administrative Officer
• Glen D Nelson,
  Director
• Robert J Thatcher,
  Executive VP
• David Martin,
  President and CEO
• Geoffrey O Hartzler,
  Director
• Brian Doughty,
  VP of Marketing
• Paul A Tyska,
  VP of Business Dev
• Roger J Howe,
  Director
• Group I, Llc Donoghue Danie...,
  
• John H Friedman,
  Director
• Scott William Kraus,
  VP Sales
• Advisors, Inc Bonderman Dav...,
  
• Geoffrey M Duyk,